Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-18-004443
Filing Date
2018-11-07
Accepted
2018-11-07 16:02:10
Documents
1
Period of Report
2018-10-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3453
  Complete submission text file 0001562180-18-004443.txt   4888
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Meyers Michael L. (Reporting) CIK: 0001664204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37708 | Film No.: 181166197